AI-Immunology™ We strive to develop novel drugs with an unprecedented level of efficacy and precision. Using AI, we simulate the human immune system and generate predictive models to identify and develop personalized and other next-generation immunotherapies for patients.
The power of AI-Immunology™ in vaccine target discovery, design and development
0
clinical trials confirm predictive capabilities and link to outcomes
0hrs
to complete target discovery
0%
fewer targets needs testing
0%+
on average cheaper target discovery versus reverse vaccinology
0%
vaccine target hit-rate
0
different modalities (protein, DNA, mRNA, peptides)
0+
different diseases can be addressed
BACTERIAL INFECTIOUS DISEASES
EDEN™ is a proprietary AI-Immunology™ model that rapidly identifies those antigens that will trigger a robust protective immune response against almost any bacterial infectious disease. EDEN™ is fully AI-driven and designed to identify vaccine candidates faster and at a lower cost than current state-of-the-art methods. With EDEN™, we take a novel approach to vaccine development with the aim of combatting the rising global issue of antibiotic resistance.
